A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million. . . . → Read More: Stem Cell Therapy Licensed for Genetic Eye Disease
|
|||||
       |
 Comments are closed  Intellectual property  Asia, biomedical, biotechnology, clinical trials, Europe, FDA, Japan, licensing, life sciences, pharmaceuticals, stem cells 
A small-scale clinical trial shows most patients with two blood-related cancers safely respond to immune system cells derived from umbilical cord blood. . . . → Read More: Blood Cancers Respond to Cord Blood Cells Comments are closed New products biomedical, biotechnology, cancer, clinical trials, genomics, Japan, licensing, life sciences, pharmaceuticals, stem cells, university 
A new report from National Science Foundation shows China now ranks a close second to the U.S. in total research and development investments. . . . → Read More: Infographic – China Closes R&D Funding Gap 
A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma. . . . → Read More: Synthetic Bio Cancer Immunotherapy Company Acquired Comments are closed Finance Asia, biomedical, biotechnology, cancer, equity, investment, Japan, life sciences, merger, pharmaceuticals 
Results from a clinical trial show an experimental treatment encourages immune-system tolerance of gluten, preventing intestinal damage from celiac disease. . . . → Read More: Trial Shows Nanotech Drug Induces Gluten Tolerance Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, clinical trials, Japan, licensing, life sciences, nanotechnology, pharmaceuticals, university 
A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million in its initial public offering of common stock. . . . → Read More: Migraine Drug Developer Raises $82.5M in IPO Comments are closed Finance biomedical, chemistry, clinical trials, equity, investment, IPO, Japan, life sciences, medical device, pharmaceuticals, physical sciences 
Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group. . . . → Read More: Sumitomo Dainippon, Biotechs in $3B Acquisition Deal Comments are closed Finance Asia, biomedical, biotechnology, equity, Europe, investment, Japan, life sciences, medical device, merger, pharmaceuticals, U.K. 
A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma. . . . → Read More: Hearing Loss Cell Therapy Licensed in $625M Deal Comments are closed Intellectual property Asia, biomedical, biotechnology, clinical trials, Japan, licensing, life sciences, pharmaceuticals, university 
A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing. . . . → Read More: Stem Cell Start-Up Raises $250M in Venture Funds One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, Japan, licensing, manufacturing, pharmaceuticals, stem cells, university, venture capital 
Techniques analyzing data from across the genome that reveal risks of diseases, better predict disorders in the main ethnicity of the population studied than other ethnic groups. . . . → Read More: Genetic Risk Analysis Shows Ethnic Bias One comment - (Comments are closed) New products Asia, biomedical, genomics, health care, Japan, life sciences, mathematics, medical device, physical sciences, U.K., university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts